leisure time -WSS

leisure time

author：leisure time 2025-09-28 13:23:36 - browse：218

Novo Nordisk Denmark — LISELOTTE SABROE/AFP/Getty Images

A pill being developed by Danish drugmaker Novo Nordisk may lead to greater weight loss than the obesity therapy Wegovy, the company reported Thursday, citing early data.

In a Phase 1 trial, participants experienced an average of 13.1% weight loss after 12 weeks of taking the experimental oral medicine amycretin, according to data presented at an investor meeting. In comparison, in an earlier Phase 3 trial of the injectable drug Wegovy, people taking Wegovy lost about 6% of their body weight over the same time period.

Novo Nordisk has been on a mission to capitalize on its success with Wegovy, which brought in $4.5 billion in sales last year. (The drug is also sold as a diabetes treatment under the name Ozempic. That version of the drug brought in another $14 billion in sales).

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： A deep dive into Applied Therapeutics’ data, and questions on Cassava

WSS

DeepMind touts AlphaFold's new skills as protein folding AI models face off

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

Infant mortality in U.S. rose last year for first time in decades: CDC

First medicine developed to treat MASH expected to be approved soon

Gene therapy’s promise and the high cost of hope

RSV shot was 90% effective at preventing hospitalizations in kids

focus

leisure time

knowledge

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Precocious puberty in girls comes with mental health risks

Novavax promises a turnaround & Lilly roils the obesity market

RSV shot was 90% effective at preventing hospitalizations in kids

Walensky prepares to leave CDC — and Congress — behind

Gene therapy’s promise and the high cost of hope

United colonoscopy coverage change 'may cost lives,' doctors say

Amylyx ALS drug fails large clinical trial

Medical records are filled with copy

IVF, abortion rights issues kick off Biden’s State of the Union

focus

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

IVF, abortion rights issues kick off Biden’s State of the Union

The drug industry has found itself all alone in Washington

DeepMind touts AlphaFold's new skills as protein folding AI models face off

RSV shot was 90% effective at preventing hospitalizations in kids

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

explore

hotspot

hotspot

leisure time